January 23, 2025Medicina15 citationsOpen Access
Key Updates to the 2024 ESC Hypertension Guidelines and Future Perspectives
Structured PICO
P
Population
Patients with hypertension
I
Intervention
Comprehensive management strategies including lifestyle interventions, single-pill combinations, stringent BP targets (<130/80 mmHg), SGLT2 inhibitors, renal denervation, and digital tools
The 2024 ESC hypertension guidelines emphasize a multifaceted, patient-centered approach including stringent BP targets (<130/80 mmHg), single-pill combinations, and digital tools to optimize BP control.
Abstract
Hypertension remains a critical global health challenge, significantly contributing to cardiovascular morbidity and mortality despite advancements in treatment. The 2024 ESC hypertension guidelines address persistent gaps in hypertension management by emphasizing comprehensive strategies encompassing early detection, socioeconomic barriers, lifestyle interventions, and personalized care. Enhanced screening protocols, including home and ambulatory blood pressure monitoring, aim for accurate diagnosis and risk stratification. Lifestyle recommendations now prioritize reducing sodium intake, increasing potassium consumption, and integrating tailored exercise regimens. Pharmacological updates advocate for single-pill combinations and stringent BP targets (<130/80 mmHg), emphasizing the benefits of sodium-glucose cotransporter-2 inhibitors for specific comorbidities. Minimally invasive therapies like renal denervation are explored for resistant hypertension, while digital tools such as telehealth and mobile applications enhance patient engagement and adherence. This multifaceted, patient-centered approach provides a roadmap for optimizing BP control, reducing cardiovascular risks, and addressing the complexities of hypertension in diverse populations.